Iproniazid

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

---

Iproniazid chemical structure Iproniazid
N'-propan-2-ylpyridine-4-carbohydrazide IUPAC name
CAS number 54-92-2	ATC code N06AF05
PubChem 3748	DrugBank [1]
Chemical formula	{{{chemical_formula}}}
Molecular weight	179.219
Bioavailability	?
Metabolism	?
Elimination half-life	?
Excretion	?
Pregnancy category	?
Legal status	?
Routes of administration	?

Iproniazid (iproniazid phosphate, marketed under the names Marsilid®, Iprozid®, Ipronid®, Rivivol®, Propilniazida®) is a monamine oxidase inhibitor (MAOI) that was developed as the first anti-depressant. It was originally intended to treat tuberculosis when it was discovered that patients given iproniazid became "inappropriately happy," subsequently with further research iproniazid was marketed specifically for depression in 1958. It was later replaced by less hepatotoxic drugs.

See also

• Amine oxidase inhibitors
• Antidepressant drugs
• Antihypertensicve drugs
• Antitubercular drugs
• Monoamine oxidase inhibitors